New COVID-19 strategy: Vaccinate potential superspreaders first
With thousands of scientists around the world racing to develop a vaccine for COVID-19, policymakers may need to decide who is at the front...
Five things you need to know about COVID-19 mRNA vaccine safety
The world's first mRNA vaccine has begun its rollout after being produced at unprecedented speed as part of the global effort to end the...
New COVID-19 test can measure your immune response for better diagnosis
In a new study, researchers have developed a new approach for COVID-19 testing that detects a distinct pattern of immune gene expression in infected...
Two common health problems may increase risk of COVID-19 brain damage
In a new study, researchers found that Some people with COVID-19 are at higher risk of brain complications like bleeding in the brain and...
This study shows a new way to stop COVID-19 infection
In a recent study at Johns Hopkins Medicine, researchers found the key to stopping COVID-19 devastating impact—blocking a protein that enables the virus to...
What you need to know about the COVID-19 vaccine
A Food and Drug Administration (FDA) panel could vote as early as today on whether to grant emergency use authorization (EUA) for Pfizer’s COVID-19...
If you already had COVID-19, let others get the vaccine, study says
In a new study, researchers found that people who already had COVID-19 may step aside and give their place in the vaccine line to...
Am I losing my sense of smell or is it COVID-19?
Do I have COVID-19 or is it something else?
This question has probably crossed your mind a time or two — or maybe even 20.
COVID-19...
This new calculator could help determine who should get COVID-19 vaccines first
In a new study, researchers developed a new online calculator for estimating the individual and community-level risk of dying from COVID-19.
They expect it to...
This two-drug combo shows promise for treating COVID-19
In a new study, researchers found that The combination of baricitinib, an anti-inflammatory drug, and remdesivir, an antiviral, reduced time to recovery for people...